NextCure, Inc. — Form D

NextCure, Inc. of BELTSVILLE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-10. The offering totals $21.5M, of which $21.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Anne G BorgmanDirectorBeltsville, MD
Ellen G FeigalDirectorBeltsville, MD
John G HoustonDirectorBeltsville, MD
Elaine V JonesDirectorAustin, TX
David P KabakoffDirectorBeltsville, MD
Michael RichmanDirectorBeltsville, MD
Stephen G WebsterDirectorBeltsville, MD
Steven P CobournExecutive OfficerBeltsville, MD
Udayan G GuhaExecutive OfficerBeltsville, MD
Sourav G KunduExecutive OfficerBeltsville, MD
Timothy G MayerExecutive OfficerBeltsville, MD
Michael RichmanExecutive OfficerBeltsville, MD
Kevin G ShawExecutive OfficerBeltsville, MD
Judith LiDirectorSan Diego, CA
David KabakoffDirectorBrisbane, CA
Asher RubinExecutive OfficerBaltimore, MD
Michael YiDirectorSouth San Francisco, CA
Stella XuDirectorBeltsville, MD
Chau Q KhuongDirectorBeltsville, MD
Kevin N HellerExecutive OfficerBeltsville, MD
Steven CobournExecutive OfficerBeltsville, MD
Tim Q ShannonDirectorBeltsville, MD
Elaine N JonesDirectorBeltsville, MD
CAROLYN GREENDirectorGERMANTOWN, MD
JUDITH Q LIDirectorGERMANTOWN, MD

Other filings by this issuer (2)

FiledFormOfferingSold
2018-11-19D$93.4M$93.4M
2016-01-11D$67.0M$15.0M

More